How phospholipid infusions boost NAD effectiveness: An interview with Dr. Krishna Doniparthi

Board-certified in family medicine, regenerative and functional medicine, and obesity medicine, Dr. Krishna Doniparthi has been practicing pain management since 2014. He is a member of American Academy of Pain Management (AAPM), American Academy of Pain Medicine, Georgia Society of Interventional Pain Physicians (GSIPP). He trained in intravenous NAD administration with Dr. Richard Mestayer and BR+MD Consultants and is a member of the NAD Research Advisory Board and the American Society of Addiction Medicine (ASAM). He is also the founder of Doniparthi Neurogen Academy, where he serves as the primary educator on phospholipids and NAD. Separately, he is a certified Medical Review Officer (MRO) for urine drug testing.

His expertise in using biological substrates, such as phospholipids, NAD+, and other essential compounds like vitamins and minerals, to support cellular health and detoxification aligns with functional medicine principles, which seek to address the root causes of health issues. He spoke with us via Zoom.

Continue readingHow phospholipid infusions boost NAD effectiveness: An interview with Dr. Krishna Doniparthi

NAD’s central role in the future of medicine

An interview with Dr. Fenton Le Bon

Fenton Le Bon, MD, MBA, is a licensed psychiatrist, medical practice developer, and the co-founder and CEO of Molecular World Health, a new company created to offer medical therapeutics based on key foundational molecules already present in the body to optimize wellness, healthy aging, and the treatment and prevention of disease.

Dr. Le Bon has spent most of his career in traditional psychiatric practice and building alternative medical clinics in the US and Argentina. In Miami, he founded a private psychiatric and corporate consulting practice, focusing on new treatment modalities for eating disorders and addiction medicine. In Georgia, he founded Eastman Mental Health, an integrated multidisciplinary outpatient practice, treating adults, adolescents and children for general psychiatric disorders, as well as developing programs such as state-based in-patient long-stay wilderness programs for the treatment of substance use. In Argentina, he founded Las Sierras Healing and Empowerment, a clinic treating substance use disorders. Now returned to the States, he is working to advance nonprescription NAD treatment delivery options to support as many people as possible in managing or eliminating chronic pain, restoring cognitive functioning, maintaining sobriety, and optimizing wellness.

Continue readingNAD’s central role in the future of medicine

An exciting time for NAD research: An interview with Dr. Susan Broom Gibson

Susan Broom Gibson, PhD, is an associate professor of psychology, School of Natural and Behavioral Sciences, William Carey University, in Hattiesburg, MS, and a research consultant for Springfield Wellness Center and NAD Research, Inc., where she also co-chairs the advisory board. She received her PhD in experimental psychology from the University of Mississippi in 2002 and completed research associate/fellowship positions at Boston University School of Medicine and Tulane University School of Medicine. Her areas of specialty include: the neuro-mechanisms of drug abuse and withdrawal, animal models of drug abuse and stress, and alternative treatment for substance use disorders. 

Over the past 15 years she has participated in research in the therapeutic potential of intravenous administration of NAD for the treatment of acute withdrawal symptoms associated with substance use disorders and Parkinson’s, in the therapeutic potential of intranasal (sphenocatheter) administration of NAD for migraines, and the maintenance of symptoms associated with Parkinson’s Disease. She spoke with us via Zoom in March 2023. 

Continue reading

Utilizing light to optimize intravenous NAD effectiveness

An interview with Michael Payne, MS, CRC, CNS

Michael Payne is perhaps the world’s leading specialist in the field of photobiomodulation therapy (PBMT) and NAD supplementation.

PBMT utilizes non-ionizing forms of light (including LASERS, LEDs, and broadband light) in the visible and near infrared spectrum. Without involving heat, it activates endogenous chromophores to begin photophysical and photochemical processes.

There are numerous examples of light-induced photochemical reactions in biological systems. Vision, for example, results when light interacts with photosensitive cells in our retinas, which convert light energy into electrical signals that are transmitted to the visual processing centers of the brain. Similarly, our skin produces vitamin D as a result of sunlight activating a form of cholesterol, 7-dehydrocholesterol, converting it to vitamin D3. The negative effects of the absence of light on the human body are also well known. Two examples include seasonal affective disorder (SAD) and lack of vitamin D production leading to rickets.

Continue readingUtilizing light to optimize intravenous NAD effectiveness

In a nutshell: summarizing our current knowledge of NAD and where we go next

An interview with Dr. Ross Grant

Dr. Ross Grant

Dr. Ross Grant is a biochemical pharmacologist and CEO of the Australasian Research Institute at Sydney Adventist Hospital. Dr. Grant has co-authored more than 100 academic articles in his research area, which focuses on understanding how a person’s lifestyle factors change their body’s biochemistry and immune activity, driving it toward either health or disease. In particular, he is interested in the influence of lifestyle factors on natural killer (NK) cell activity, redox balance (oxidative stress), and NAD+ metabolism, and how these influence cellular degeneration, particularly in the brain and central nervous system. He is a member of the Australian Neuroscience society (ANS), Nutrition Society of Australia (NSA), Australasian Society of Lifestyle Medicine, serves on the Advisory Board of NAD Research, Inc., and is one of our primary research partners.

Continue readingIn a nutshell: summarizing our current knowledge of NAD and where we go next